@Mark_Farha received best poster at #AUA26's "IP50: Bladder Cancer-Non-Invasive IV" for his research, "FGFR3 Mutation w/ CDKN2A Deletion Defines an Aggressive Subtype w/ Poor Outcomes Across the Grade Spectrum for Non-Muscle Invasive Bladder Cancer" under Dr. Pietzak. Congrats!
This week marks IVU's first trip to Liberia, where the team will be conducting a combined Reconstructive and Oncology Workshop.π±π·
The team is led by IVU board member, Dr. Jay Smith. IVU Resident Scholar Dr. Mark Farha from Cornell, is also there sponsored by the @NYSAUA